|
|
The Epilepsy Therapy Project supports innovative research in both academic and industry settings through direct grants and investments. Learn about our programs and how the Epilepsy Therapy Project is supporting research and helping to advance new therapies.
Epilepsy Research FoundationThe mission of the Epilepsy Research Foundation is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient. Read more
New Therapy Grants Program / Apply for Grant Funding
The New Therapy Grants Program provides grants supporting the research and development of new therapies, including new medicines and therapeutic devices, in both academic and commericial settings worldwide. Consistent with the theme of translational research, all grant proposals must demonstrate a clear path from the lab to the patient. Read more
Commercialization Grants / Apply for Grant Funding
1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. These matching funds seek to leverage other resources, and accelerate the pace of therapeutic advance. Read more
Milken Family Foundation Translational Research Awards / Apply for Grant Funding
The Milken Family Foundation has a remarkable history of medical philanthropy and in particular a longstanding and unique commitment to advancing cures for epilepsy. The MFF Translational Research Awards target the area of greatest need and potential impact in this therapy pipeline—the translation of basic research to therapeutic product candidates. The Foundation will favor proposals focused on women with epilepsy and their unique issues during child-bearing years. Read more
Funding Portfolio
The Epilepsy Therapy Project directly supports promising new therapies and emerging epilepsy focused companies through research awards and equity investments. Review the list of funded projects and investments in this section. Read more
Other Sources of Funding
View the list of additional funding sources here. Read more